Septerna (SEPN) Other Non Operating Income (2023 - 2026)
Septerna's (SEPN) quarterly Other Non Operating Income came in at -$31000.0 in Q1 2026, down 10.71% year-on-year from -$34720.0 in Q1 2025, and down 102.72% quarter-over-quarter from $1.1 million in Q4 2025.
Septerna (SEPN) Other Non Operating Income (2023 - 2026) Analysis & Trends
Septerna's Other Non Operating Income history runs 4 years deep, the most recent figure standing at -$31000.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 10.71% year-over-year to -$31000.0 in Q1 2026; TTM through Mar 2026 was $1.1 million, a 1640.0% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, up 1301.11% from the prior year.
- Other Non Operating Income slipped to -$31000.0 in Q1 2026 per SEPN's latest filing, from $1.1 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $1.1 million in Q4 2025 and bottomed at -$48000.0 in Q1 2024.
- The 4-year median for Other Non Operating Income is -$15000.0 (2024), against an average of $88363.6.
- Across the five-year window, Other Non Operating Income plunged 800.0% in 2024 and surged 6433.33% in 2025, its largest moves.
- Year by year, Other Non Operating Income stood at $13000.0 in 2023, then sank by 238.46% to -$18000.0 in 2024, then jumped by 6433.33% to $1.1 million in 2025, then sank by 102.72% to -$31000.0 in 2026.
- Per Business Quant, the three latest SEPN Other Non Operating Income figures stand at -$31000.0 (Q1 2026), $1.1 million (Q4 2025), and -$6000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Septerna | 1.50 Bn | 1.50 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31,000.00 |
| Dec 31, 2025 | 1.14 Mn |
| Sep 30, 2025 | -6,000.00 |
| Jun 30, 2025 | -25,000.00 |
| Mar 31, 2025 | -28,000.00 |
| Dec 31, 2024 | -18,000.00 |
| Sep 30, 2024 | -9,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Mar 31, 2024 | -48,000.00 |
| Dec 31, 2023 | 13,000.00 |
| Sep 30, 2023 | -1,000.00 |